Awakn Life Sciences Corp.
AWKNF · OTC
1/31/2024 | 1/31/2023 | 1/31/2022 | 1/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3,514 | $8,538 | $44,087 | $24,009 |
| - Cash | $407 | $551 | $1,623 | $366 |
| + Debt | $0 | $2,296 | $1,809 | $132 |
| Enterprise Value | $3,107 | $10,283 | $44,273 | $23,775 |
| Revenue | $87 | $1,495 | $236 | $0 |
| % Growth | -94.2% | 533.5% | – | – |
| Gross Profit | $87 | $892 | -$277 | $0 |
| % Margin | 100% | 59.6% | -117.3% | – |
| EBITDA | -$3,908 | -$5,263 | -$16,085 | -$840 |
| % Margin | -4,473% | -352% | -6,814.6% | – |
| Net Income | -$5,103 | -$9,143 | -$15,946 | -$1,260 |
| % Margin | -5,840.1% | -611.4% | -6,755.7% | – |
| EPS Diluted | -0.18 | -0.36 | -0.73 | -0.1 |
| % Growth | 50% | 50.7% | -631.5% | – |
| Operating Cash Flow | -$2,381 | -$7,364 | -$8,586 | -$473 |
| Capital Expenditures | $0 | -$95 | -$1,707 | -$201 |
| Free Cash Flow | -$2,381 | -$7,459 | -$10,293 | -$674 |